Jaguar Health, Inc. (JAGX) — Analyst outlook / Analyst consensus target is. Based on 5 analyst ratings, the consensus is bullish — 5 Buy.
The consensus price target is $12.98, representing an upside of 2968.6% from the current price $0.42.
Analysts estimate Earnings Per Share (EPS) of $-20.00 and revenue of $0.01B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-130.69 vs est $-20.00 (missed -553.5%). Analyst accuracy: 15%.
JAGX Stock — 12-Month Price Forecast
$12.98
▲ +2,968.56% Upside
Average Price Target
Based on 5 Wall Street analysts offering 12-month price targets for Jaguar Health, Inc., the price target is $12.98.
The average price target represents a +2,968.56% change from the last price of $0.42.
JAGX Analyst Ratings
Buy
Based on 5 analysts giving stock ratings to Jaguar Health, Inc. in the past 3 months
EPS Estimates — JAGX
15%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024
Actual –$130.69
vs Est –$20.00
▼ 84.7% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — JAGX
97%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2024
Actual $0.012B
vs Est $0.011B
▲ 3.3% off
Revenue Trend
Analysts expect stable revenue going forward.
